Stevanato Group S.p.A (STVN) Cost of Revenue (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Cost of Revenue of $232.3 million for Q1 2026, up 18.27% year-over-year from $196.4 million in Q1 2025, and down 16.72% quarter-over-quarter from $278.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cost of Revenue (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Cost of Revenue for 7 consecutive years, with $232.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 18.27% year-over-year to $232.3 million; the TTM figure through Mar 2026 stood at $990.2 million (up 13.17% YoY), while the FY2025 annual figure was $980.6 million, up 14.46% from the prior year.
- Cost of Revenue declined to $232.3 million in Q1 2026 per STVN's latest filing, from $278.9 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $278.9 million in Q4 2025 and bottomed at $162.3 million in Q1 2022.
- Historically, Cost of Revenue has averaged $209.3 million across 5 years, with a median of $205.2 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue declined 5.2% — and 2023, when it gained 21.36%.
- Stevanato Group S.p.A's Cost of Revenue stood at $195.8 million in 2022, then grew by 20.24% to $235.4 million in 2023, then climbed by 5.49% to $248.3 million in 2024, then climbed by 12.31% to $278.9 million in 2025, then slipped by 16.72% to $232.3 million in 2026.
- Business Quant data shows STVN's Cost of Revenue at $232.3 million in Q1 2026, $278.9 million in Q4 2025, and $251.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 250.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250.13 Mn |
| Jun 30, 2026 | 250.13 Mn |
| Mar 31, 2026 | 232.28 Mn |
| Mar 31, 2026 | 232.28 Mn |
| Dec 31, 2025 | 278.90 Mn |
| Dec 31, 2025 | 278.90 Mn |
| Sep 30, 2025 | 250.96 Mn |
| Sep 30, 2025 | 250.96 Mn |
| Jun 30, 2025 | 228.03 Mn |
| Jun 30, 2025 | 228.03 Mn |
| Mar 31, 2025 | 196.39 Mn |
| Mar 31, 2025 | 196.39 Mn |
| Dec 31, 2024 | 248.34 Mn |
| Dec 31, 2024 | 248.34 Mn |
| Sep 30, 2024 | 223.40 Mn |
| Sep 30, 2024 | 223.40 Mn |
| Jun 30, 2024 | 206.82 Mn |
| Jun 30, 2024 | 206.82 Mn |
| Mar 31, 2024 | 188.81 Mn |
| Mar 31, 2024 | 188.81 Mn |